Gene · 156
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis. | BMC Med Genomics | 2022 | 36209090 | PubTator, text mining | PubMed |
| An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma. | Front Pediatr | 2022 | 36204661 | PubTator, text mining | PubMed |
| Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes. | Front Pharmacol | 2022 | 36188529 | PubTator, text mining | PubMed |
| Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation. | Oxid Med Cell Longev | 2022 | 36187336 | PubTator, text mining | PubMed |
| Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells. | Pharmacol Res Perspect | 2022 | 36177761 | PubTator, text mining | PubMed |
| Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective. | Curr Opin Endocr Metab Res | 2022 | 36177190 | PubTator, text mining | PubMed |
| Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor. | Science | 2022 | 36173843 | PubTator, text mining | PubMed |
| Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. | Front Cardiovasc Med | 2022 | 36172573 | PubTator, text mining | PubMed |
| BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes. | Cancer Biol Ther | 2022 | 36170346 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Quantitative Phosphoproteomics Analysis Uncovers PAK2- and CDK1-Mediated Malignant Signaling Pathways in Clear Cell Renal Cell Carcinoma. | Mol Cell Proteomics | 2022 | 36152754 | PubTator, text mining | PubMed |
| Consequences of PDGFRα+ fibroblast reduction in adult murine hearts. | Elife | 2022 | 36149056 | PubTator, text mining | PubMed |
| Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. | Front Genet | 2022 | 36147504 | PubTator, text mining | PubMed |
Demographics, Radiological Findings, and Clinical Outcomes of Klebsiella pneumonia vs. Non-Klebsiella pneumoniae Pyogenic Liver Abscess: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. | Pathogens | 2022 | 36145408 | PubTator, text mining | PubMed |
| Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options? | Int J Mol Sci | 2022 | 36142245 | PubTator, text mining | PubMed |
| Circulating microRNAs in Hidradenitis Suppurativa. | Genes (Basel) | 2022 | 36140712 | PubTator, text mining | PubMed |
| Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting. | Cells | 2022 | 36139408 | PubTator, text mining | PubMed |
| Unraveling axonal mechanisms of traumatic brain injury. | Acta Neuropathol Commun | 2022 | 36131329 | PubTator, text mining | PubMed |
| Emerging roles of neutrophils in immune homeostasis. | BMB Rep | 2022 | 36104260 | PubTator, text mining | PubMed |
| Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies. | JCI Insight | 2022 | 36099030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/156/papers?page=21